Country: Իռլանդիա
language: անգլերեն
source: HPRA (Health Products Regulatory Authority)
PRAZIQUANTEL
Bayer Limited
QP52AA01
PRAZIQUANTEL
50.0 mg/tablet
Tablets
CAM-Companion Animal Medicine
Canine, Feline
Praziquantel
Endoparasiticide
Authorised
1989-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Droncit Tablets 50mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION MG PER TABLET Praziquantel 50.0 For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Tablet. White round tablet scored on one side. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of adult tapeworms of dogs and cats. The tablets are effective against both immature and mature forms of adult tapeworms in both dogs and cats. The product is a highly effective treatment against all the common species of tapeworm infecting dogs and cats in the United Kingdom and Ireland including_ Echinococcus granulosus_,_ Taenia ovis, Taenia pisiformis, Taenia multiceps, Taenia_ _hydatigena, Taenia taeniaeformis,_ and_ Dipylidium caninum._ Droncit is also effective against_ Echinococcus multilocularis_ (see 4.4) 4.3 CONTRAINDICATIONS Do not administer to dogs weighing less than 2.5 kg Do not administer to unweaned puppies and kittens, as such animals are rarely infected with tapeworms. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Fleas serve as intermediate hosts for one common type of tapeworm-_Dipylidium caninum_. To avoid reinfection with this parasite, flea control of the animal and its housing should be carried out at the same time. Unless flea control is complete an infected flea population may survive: i.e. re-treatment of the animal may be necessary. As a precautionary measure to prevent establishment of_ Echinococcus multilocularis_ in the UK and Ireland it is recommended that all dogs entering the country be treated with praziquantel. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ read_full_document